Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/02/2003US6613738 Comprising 1,2-dihydroxy-homotyrosine, 4-hydroxyproline, threonine, glutamine, 3-,4-dihydroxymethylproline, 4,5-dihydroxyornithine and lipid
09/02/2003US6613737 Fractionating serum/blood plasma by chromatography and electrophoresis; sperm-motility promoting glycoprotein
09/02/2003US6613736 Determining respiratory quotient(RQ), have patient consume liquid or food containing glucose, administering pulse of insulin at regular time interval until the RQ reaches a specified value; enhances pyruvate dehydrogenase activity
09/02/2003US6613734 Peptides-containing liposomal surfactants
09/02/2003US6613573 Blood coagulation analyzer for determining the efficacy of anti-coagulant therapy by measuring blood clot strength; use in treatment of clotting disorders and in surgical and medical procedures
09/02/2003US6613567 Antisense inhibition of Her-2 expression
09/02/2003US6613565 Use of delta-like protein to inhibit the differentiation of stem cells
09/02/2003US6613563 Viral vectors with modified tropism
09/02/2003US6613546 DNA; genomes; axons; exons; introns; splicing/genetic/; use to produce "useful protein" by animal cells transformed with expression vector comprised of nucleic acid encoding the "useful protein" and linked to DNA having promoter activity
09/02/2003US6613544 Osteoprotegerin
09/02/2003US6613536 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans
09/02/2003US6613526 Contacting mixture of nucleic acid sequences with blood brain barrier or CSF-blood barrier tissue; partitioning increased affinity nucleic acids from candidate mixture; amplifying increased to yield a mixture of nucleic acids
09/02/2003US6613515 Nucleotide sequences; polynucleotides; carcinoma proteins; polypeptides; antibodies; T-cells; vaccines; drugs; use of polypeptides, antibodies, polynucleotides and T-cells in vaccines and antitumor agents for treatment of ovarian cancer
09/02/2003US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences
09/02/2003US6613507 Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
09/02/2003US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings
09/02/2003US6613342 System and method for treating kidney diseases in diabetic and non-diabetic patients
09/02/2003US6613337 Preventing, treating and detecting leishmaniasis and stimulating immune responses in patients. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens.
09/02/2003US6613335 Provided are BASB011 polypeptides and polynucleotides encoding BASB011 polypeptide from Moraxella catarrhalis. Also provided are immunogenic uses.
09/02/2003US6613332 Oral administration of therapeutic proteins
09/02/2003US6613331 Vaccine against Lyme disease
09/02/2003US6613330 Methods and compositions for preventing anti-Gal production in xenograft recipients
09/02/2003US6613329 Vaccine and antitoxin for treatment and prevention of C. difficile disease
09/02/2003US6613327 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal
09/02/2003US6613326 Antitoxins and methods for making antitoxins
09/02/2003US6613325 Applying with thrombin to said surgical wound site under polymerizing conditions such that a fibrin polymer is formed
09/02/2003US6613322 Administering enzyme inhibitors
09/02/2003US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression
09/02/2003US6613319 Long-term expression of erythropoietin and growth hormone by transforming muscle cells
09/02/2003CA2151543C Immunogens for the production of cocaine-hydrolyzing catalytic antibodies
08/2003
08/28/2003WO2003071268A2 Method for discovering pharmacologically active substances
08/28/2003WO2003070984A1 Methods and reagents for detecting target binding by nucleic acid ligands
08/28/2003WO2003070983A1 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN KINASE C ALPHA (PKC-ALPHA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070972A2 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070971A2 Modulators of paraptosis and related methods
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070966A2 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003WO2003070953A1 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
08/28/2003WO2003070948A1 Cloning of the human kinase suppressor of ras-1 (ksr-1)
08/28/2003WO2003070932A1 Polynucleotide for target gene
08/28/2003WO2003070923A1 Agent for inducing or inhibiting an angiogenesis
08/28/2003WO2003070921A1 METHODS FOR PRODUCING Ϝδ T CELLS
08/28/2003WO2003070920A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
08/28/2003WO2003070919A1 Antimicrobial composition
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070917A2 Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways
08/28/2003WO2003070916A2 Dna encoding snorf44 receptor
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070912A2 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070906A2 Cellular genes regulated by hiv-1 infection and methods of use thereof
08/28/2003WO2003070905A2 Electroporation methods for introducing bioactive agents into cells
08/28/2003WO2003070904A2 Human rnase iii and compositions and uses thereof
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070897A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070896A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070895A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070892A2 Inhibitors of rgs proteins
08/28/2003WO2003070890A2 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS
08/28/2003WO2003070888A2 Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid
08/28/2003WO2003070887A2 RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070885A2 SHORT INTERFERING NUCLEIC ACID INHIBITION OF STEAROYL-CoA DESATURASE (SCD) GENE
08/28/2003WO2003070884A2 RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003WO2003070881A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070878A2 Antisense modulation of hematopoietic cell protein tyrosine kinase expression
08/28/2003WO2003070823A2 Conjugates comprising a biodegradable polymer and uses therefor
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070769A2 Organic compounds having anti-angiogenic activity
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070764A1 Method for producing interferon
08/28/2003WO2003070763A1 Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
08/28/2003WO2003070762A1 Compositions isolated from bovine mammary gland and methods for their use
08/28/2003WO2003070761A1 Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
08/28/2003WO2003070759A2 Method of modulating e-cadherin mediated cell adhesion
08/28/2003WO2003070757A1 Nucleic acid encoding an herv-h polypeptide for diagnosing colorectal cancer
08/28/2003WO2003070755A2 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
08/28/2003WO2003070754A1 Histone deacetylase inhibitors and process for producing the same
08/28/2003WO2003070753A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
08/28/2003WO2003070751A2 Partial peptide mimetics and methods
08/28/2003WO2003070750A2 Rna interference mediated inhibition of hepatitis c virus
08/28/2003WO2003070749A2 Self-assembly of peptide-amphiphile nanofibers under physiological conditions
08/28/2003WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists
08/28/2003WO2003070746A2 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070743A1 RNA INTERFERENCE MEDIATED INHIBITION OF G72 AND D-AMINO ACID OXIDASE (DAAO) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070742A1 RNA INTERFERENCE MEDIATED INHIBITION OF TELOMERASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003WO2003070291A1 Implant containing cells having growhfactor gene transferred thereinto
08/28/2003WO2003070278A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/28/2003WO2003070276A1 A preparation and method for weight reduction
08/28/2003WO2003070275A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003WO2003070269A1 Treatment for diseases of the eye, inner ear and central nervous system
08/28/2003WO2003070268A1 Remedy for infections
1 ... 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 ... 3163